ubmslateOT-logo-ubm

OT mobile menu

Search form

Topics:

TAPUR Trial Leverages Genomic Testing for Precision Medicine

TAPUR Trial Leverages Genomic Testing for Precision Medicine

Edward Kim, MD, FACP, of the Levine Cancer Institute, Carolinas Healthcare System, in Charlotte, North Carolina, discusses aspects of the ASCO-led TAPUR trial, which utilizes genomic testing to identify markers that can be targeted by specific drugs, giving certain patients access to drugs they wouldn't otherwise be able to access for their disease.

We spoke with Dr. Kim at the 2017 ASCO Annual Meeting because his institution is one of the lead sites participating in the TAPUR trial.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.